Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Exercise of Options

27 Jun 2025 07:00

RNS Number : 6335O
Spectra Systems Corporation
27 June 2025
 

Spectra Systems Corporation

(the "Company")

Exercise of Options

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies, and gaming security software, announces the exercise of options by an employee of Spectra.

The employee has exercised options over 13,700 shares of common stock of $0.01 each in the Company ("Shares") with an exercise price of 25p per share on 6 June 2025. The employee has elected to utilize the net cashless exercise feature and has therefore surrendered 1,713 shares to the Company. Accordingly, the employee will be issued 11,987 shares.

The shares being issued are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.

Accordingly, the Company has issued and will apply for 11,987 Shares to be admitted to trading on AIM, which is expected to take place on or around 2 July 2025 ("Admission").

The Company's issued share capital now comprises:

542,258 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and

47,758,431 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).

Spectra Systems has no Shares in treasury, therefore 48,300,689 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

 

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

Zeus (Nominated Adviser and Broker)

James Joyce (Director)

James Bavister (Assistant Director)

Andrew de Andrade (Associate, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 3829 5000

 

 

 

Tel: +44 (0)20 3328 5665

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFEERVIRFIE
Date   Source Headline
5th Jan 20214:02 pmRNSDirectorate
5th Jan 20217:00 amRNSShare Buy-Back
14th Dec 20207:01 amRNSTwo Lottery Renewals
14th Dec 20207:00 amRNSAcquisition of interest - Solaris BioSciences, Inc
21st Oct 20209:06 amRNSSecond Price Monitoring Extn
21st Oct 20209:01 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSContract with a Central Bank
14th Oct 20205:27 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSRemoval of Regulation S Restrictions
11th Sep 20204:34 pmRNSExercise of Options and Director/PDMR Shareholding
10th Sep 20207:00 amRNSExercise of Options and Director/PDMR Shareholding
7th Sep 20207:00 amRNSInterim Results for the Six Months 30 June 20
25th Aug 20204:11 pmRNSHolding(s) in Company
15th Jul 20206:25 pmRNSDirector Dealings
9th Jul 20207:00 amRNSContract with a Major Central Bank
26th Jun 20207:00 amRNSShare Buy-Back
25th Jun 20207:00 amRNSShare Buy-Back and Removal of Reg S Restrictions
16th Jun 20203:23 pmRNSShare Buy-Back
10th Jun 20207:00 amRNSAsian Central Bank Contract Update
26th May 20207:00 amRNSDirector Dealings
15th May 20205:24 pmRNSExercise of Options and Removal of Regulation S
30th Apr 20208:51 amRNSPosting of Annual Report and Accounts
3rd Apr 20204:56 pmRNSShare Buy-Back and Removal of Reg S Restrictions
23rd Mar 202012:37 pmRNSAudited Results
16th Mar 20201:59 pmRNSHolding(s) in Company
9th Mar 20204:41 pmRNSPrice Monitoring Extension
21st Feb 20207:00 amRNSShare Buy-Back
11th Nov 20193:30 pmRNSHolding(s) in Company
30th Oct 20191:39 pmRNSHolding(s) in Company
16th Oct 20197:00 amRNSHolding(s) in Company
25th Sep 20192:59 pmRNSHolding(s) in Company
24th Sep 20197:00 amRNSInterim Results
17th Sep 20197:00 amRNSFunding Approval - G7 Central Bank
1st Aug 20197:00 amRNSPolymer Banknote Substrate Supply Agreement
15th Jul 20197:00 amRNSNew Lottery Security Contracts
24th Jun 20197:00 amRNSAnnual General Meeting Lack of Quorum
11th Jun 20197:00 amRNSFive Year Optical Materials Supply Contract
29th May 20194:12 pmRNSExercise of Options
29th May 20197:00 amRNSTrading Update
28th May 20197:00 amRNSRemoval of Regulation S restrictions from shares
17th May 20193:21 pmRNSRemoval of Regulation S restrictions from shares
10th May 20192:31 pmRNSPosting of AGM Notice
10th May 20192:15 pmRNSShare Buy-Back
26th Apr 20198:55 amRNSPosting of Annual Report and Accounts
24th Apr 20197:00 amRNSRemoval of Regulation S Restrictions from Stock
18th Apr 20197:00 amRNSExercise of Options and Director/PDMR Shareholding
15th Apr 20197:00 amRNSUpdated CEO Employment Agreement
10th Apr 20197:00 amRNSShare Buy-Back Programme
25th Mar 20197:00 amRNSPreliminary Results
18th Mar 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.